CooperVision introduces new President, Americas Steven Robins

News
Article

Robins has worked in the healthcare industry for 3 decades in several high-profile corporate leadership and consulting roles.

Steven Robins Image credit: CooperVision

Steven Robins Image credit: CooperVision

CooperVision has appointed a new president for its Americas team. Steven Robins, most recently the managing partner and principal for The New England Consulting Group, has worked in the healthcare industry for 3 decades, with several high-profile corporate leadership and consulting roles under his belt, according to a news release.

“Since my first foray into ocular health almost 20 years ago, I have known that there’s something special about this industry, shown by the way its professionals and products come together to make the world better for millions of people every day. There are big opportunities in vision care, and CooperVision is a clear leader in several. It’s a privilege to join the company that has its sights set on becoming an even greater part of people’s lives through remarkable innovations and partnerships,” said Robins in the release.

In his work with The New England Consulting Group, Robins worked with a variety of Fortune 500 organizations in the medical device, pharmaceutical, and OTC/vitamin sectors. He also worked with CooperVision in multiple strategic engagements, including the US introduction of MiSight 1 day contact lens for myopia control. Previously, he also served as chief marketing officer and president of North American Vision Care for Bausch + Lomb, general manager of Johnson & Johnson’s Consumer Healthcare business in Canada, and as the group marketing director for Pfizer Consumer Healthcare.1

“Steven has been working with CooperVision for a number of years on strategic, priority projects including our MiSight® 1 day contact lenses,” said Debbie Olive, chief commercial officer for CooperVision, in the release. “I am impressed with his strategic thinking as well as his passion for the industry and our customers. He is a charismatic, engaging leader who undoubtedly will drive positive impacts throughout our Americas business.”

Robins holds a Bachelor of Arts from Bates College and participated in the Pfizer Global Leadership Program with Harvard University, the release stated. In his new position with CooperVision, he plans to relocate to Rochester, New York.1

Reference:
  1. CooperVision names Steven Robins as President, Americas. News release. CooperVision. January 27, 2025. Accessed January 27, 2025. https://coopervision.com/our-company/news-center/press-release/coopervision-names-steven-robins-president-americas

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Selina McGee, OD, FAAO, Dipl ABO, shares key takeaways and a personal anecdote relating to the State of Dry Eye survey results.
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO.
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.